Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.


May 4, 2018
The undersigned groups thank the Drug Enforcement Administration (DEA) for the opportunity to comment on its proposed rule regarding controlled substances quotas.
May 4, 2018
We concur with the DEA that setting quotas for the production of opioid medications can be an effective step in “preventing the accumulation of controlled substances in amounts exceeding legitimate
May 2, 2018
AHA's comments on the Centers for Medicare & Medicaid Services’ and its contractors’ draft specifications for the two transfer of health information measures under development. 
May 1, 2018
AHA responds to the US Department of Treasury Office of Tax Policy request for guidance on questions raised by new tax law.
Apr 24, 2018
AHA letter to FCC regarding concern about the unexpected and significant funding cuts for the Rural Health Care (RHC) program participants, announced in March by the Universal Service Administrative Company (USAC), the program administrator. 
Apr 23, 2018
AHA comments to CMS on the proposed rule amending the definition of short-term, limited-duration health insurance.
Apr 23, 2018
AHA comments to the House Subcommittee on Health Energy and Commerce on bills related to the opioid crisis.
Apr 12, 2018
As the nation continues to struggle with the devastating public health crisis created by the opioid epidemic, it is encouraging to see the Committee on Health, Education, Labor & Pensions take